Enhances patient recovery when used with mechanical or medication-based embolism prevention
Clinically tested graduated compression boosts circulation and minimizes vein swelling
Maintains essential DVT protection during pauses in intermittent compression therapy
$17.05
- FREE 1-2 day shipping on orders $49+
- Free 30-day returns
- 24/7 product guidance
Enhances patient recovery when used with mechanical or medication-based embolism prevention
Clinically tested graduated compression boosts circulation and minimizes vein swelling
Maintains essential DVT protection during pauses in intermittent compression therapy
Features:
Enhances patient recovery when used with mechanical or medication-based embolism prevention
Clinically tested graduated compression boosts circulation and minimizes vein swelling
Maintains essential DVT protection during pauses in intermittent compression therapy
Available in 37 sizes and 3 styles to suit a wide range of patients
Delivers ideal compression gradient from ankle to mid-thigh for effective support
1. What are T.E.D. Anti-Embolism Stockings used for?
These stockings are designed to help prevent deep vein thrombosis (DVT) and improve circulation, especially in non-ambulatory or post-surgical patients.
2. How do the stockings work?
They apply graduated compression, meaning the pressure is highest at the ankle and gradually decreases up the leg. This helps increase blood flow and reduce venous distention.
3. Can they be used with other DVT prevention methods?
Yes, they are most effective when used alongside mechanical devices or pharmaceutical blood thinners as part of a comprehensive DVT prevention plan.
| Brand | T.E.D.â„¢ |
| Manufacturer | Cardinal |
| Application | Anti-embolism Stocking |
| Circumference | Calf 23 to 26 Inch Circumference |
| Color | White |
| Gender | Unisex |
| Length | Up To 18 Inch Length |
| Size | 3X-Large / Regular |
| Style | Knee High |
| Toe Style | Open Toe |
| User | Adult |
| Select Option | 3XL/Regular – 1 Pair |
|---|









Reviews
There are no reviews yet.